EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Serum cytokeratin-18 fragments as quantitative markers of epithelial apoptosis in liver and intestinal graft-versus-host disease






Blood 110(13): 4535-4542

Serum cytokeratin-18 fragments as quantitative markers of epithelial apoptosis in liver and intestinal graft-versus-host disease

Graft-versus-host disease (GVHD) is the main complication of allogeneic stem cell transplantation. However, diagnosis of GVHD and evaluation of response to immunosuppressive treatment is sometimes difficult. Since apoptosis is the histopathologic hallmark in GVHD, we investigated whether active GVHD-induced target organ destruction is mirrored by serum levels of the caspase-cleaved neo-epitope of cytokeratin-18 fragments (CK18Fs). Serum CK18F kinetics was monitored by M30 antibody-based enzyme-linked immunosorbent assay (ELISA) in 50 patients who fulfilled histopathologic and/or clinical criteria diagnostic for GVHD. Both intestinal and hepatic GVHD were consistently associated with significant elevations of CK18F levels over baseline. Responses of GVHD to immunosuppressive therapy were paralleled by CK18F decreases, whereas resistant GVHD was characterized by persistent CK18F rises. Clinical conditions that might represent relevant differential diagnoses, such as toxic mucositis, noncomplicated, infection-related diarrhea, and veno-occlusive disease were not associated with CK18F elevations. In conclusion, CK18F monitoring provides a serum marker for quantitative assessment of GVHD-associated apoptotic activity in intestinal and hepatic GVHD. Although apoptosis is not GVHD-specific, CK18Fs may help to distinguish active GVHD from GVHD-unrelated conditions with similar symptoms, and to monitor response to immunbsuppressive treatment. Prospective studies are warranted to evaluate how CK18Fs may assist in the diagnosis, grading, and treatment guidance of GVHD.

(PDF same-day service: $19.90)

Accession: 021739630

PMID: 17702900

DOI: 10.1182/blood-2006-10-049817



Related references

Cytokeratin fragments in serum possible new markers for the follow up of patients with inflammatory liver disease. Gastroenterology 96(5 PART 2): A673, 1989

Graft-versus-host disease-related cytokine-driven apoptosis depends on p73 in cytokeratin 15-positive target cells. Biology of Blood and Marrow Transplantation 18(6): 841-851, 2013

An epithelial target site in experimental graft-versus-host disease and cytokine-mediated cytotoxicity is defined by cytokeratin 15 expression. Biology of Blood and Marrow Transplantation 9(9): 559-570, 2003

Paradoxical effects of IFN-gamma in graft-versus-host disease reflect promotion of lymphohematopoietic graft-versus-host reactions and inhibition of epithelial tissue injury. Blood 113(15): 3612-3619, 2009

Serum markers of graft-versus-host disease after bone marrow transplantation. Journal of Allergy & Clinical Immunology 106(1 Part 2): S40-S44, July, 2000

Apoptosis is the predominant form of epithelial target cell injury in acute experimental Graft-versus-host disease. Journal Of Investigative Dermatology. 107(3): 377-383, 1996

Effect of cyclosporin a treatment on the enteropathy of graft versus host reaction in the rat a quantitative study of intestinal morphology epithelial cell kinetics and mucosal immune activity. Immunology & Cell Biology 67(3): 153-160, 1989

Use of anti-CD3 epsilon F(ab')2 fragments in vivo to modulate graft-versus-host disease without loss of graft-versus-leukemia reactivity after MHC-matched bone marrow transplantation. Journal of Immunology 154(10): 5542-5554, 1995

Use of anti-CD3e F(ab')2 fragments in vivo to modulate graft-versus-host disease without loss of graft-versus-leukemia reactivity after MHC-matched bone marrow transplantation. Journal of Immunology 154: 42-54, 1995

Studies of the mechanisms of intestinal epithelial cell injury in nippostrongylus brasiliensis nb infection and graft versus host disease gvhd. Gastroenterology 92(5 PART 2): 1424, 1987